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Somatostatin is a circulating peptide hormone that displays an
array of biological actions, including the inhibition of hormone
secretion, modulation of neural transmission and regulation of
cell growth (F l o r i o et al., 1999). At the periphery, SRIH in-
hibits the secretion of several non-pituitary hormones such as
insulin, glucagon, gastrin, secretin and aldosterone (R e i c h -
l i n , 1983; M i l o š e v i ć , 1999). Within the nervous system,
SRIH acts as a neuromodulator, affecting neuroendocrine, mo-
tor, and cognitive functions (R e i c h l i n , 1983; E p e l b a u m
et al., 1994). Because of its ability to inhibit secretory functions
of various organs, its therapeutic value in clinical conditions is
recognized and used.
In view of the above, the purpose of this study was to ex-
amine the effects of administration of SRIH-14 on morpholog-
ical and stereological features of adrenal zona glomerulosa
(ZG) cells in neonatal female rats.
Time-mated pregnant Wistar rats were housed individually
and maintained in a controlled environment (12 h light: 12 h
dark; 22 ± 2°C), with food (product of Veterinarski zavod Sub-
otica, Subotica, Serbia and Montenegro) and water freely avail-
able. Female pups of the first group were injected s.c. twice a
day (8 am and 8 pm) with 20 mg of SRIH-14 (S9129, Sigma, St.
Louis, Mo., USA) per 100g b.w. for five consecutive days (from
the 3rd to 7th day of life). Those of the second group  served as
the control, and  received physiological saline. All animals were
sacrificed by decapitation under deep anesthesia 12 h after the
last treatment. Experimental protocols were ones approved by
the Local Animal Care Committee and conformed to the recom-
mendations given in “Guide for the Care and Use of Laborato-
ry Animals” (1996, National Academy Press, Washington, D.
C.).
The left adrenal gland was excised, fixed in Bouin’s solu-
tion, embedded in paraffin, and serially cut into sections 5 mm
thick. The sections were stained with hematoxylin-eosin and
stereologically analyzed using the M42 multipurpose test system
inserted into the ocular of a Zeiss light microscope. The volume
densities of nuclei and cytoplasm of parenchymal cells were es-
timated at a total magnification of x 1000. For each adrenal
gland, a single paraffin section containing medulla was chosen
and 30 test areas of the ZG were stereologically analyzed. On
the basis of earlier karyometric studies (M a l e n d o w i c z ,
1974), the b shape coefficient was assumed to be 1.500 for ZG
cells. It relates Nv (number of cells counted per unit of volume)
to Na (number of cells counted per mm
2) and Vv (volume den-
sity) and depends on the axial ratio of estimated nuclei. The
number of adrenocortical cell nuclei per mm3 was calculated
according to the method of  We i b e l (1979). 
The ZG cells were arranged in closely packed ovoid clus-
ters. The cells were relatively small, columnar or pyramidal in
shape. Their nuclei were round or oval, with an evidenced nu-
cleolus. In these cells lipid droplets were observed. The shape
of ZG cells in animals neonatally treated with SRIH-14 was not
significantly changed, but the cytoplasm of these cells was
darkly stained in comparison to the controls (Fig. 1A, B). Abso-
lute and relative volumes of the ZG were significantly (p <
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Fig. 1. Histochemically labelled ZG cells in adrenal cortex of female
rats in: A. control rats, B. after multiple treatment with SRIH-14. (H&E,
objective magnification x 40).
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0.05) reduced by 36% and 20%, respectively, in comparison
with control values (Table 1). The volumes of ZG cells and their
nuclei were significantly (p < 0.05) reduced by 7% and 15%, re-
spectively,  in comparison with control values.
Our results strongly suggest that neonatal treatment of fe-
male rats with SRIH-14 suppresses growth of the adrenal ZG
and its cells. These results are in accordance with earlier obser-
vations of M a z z o c c h i et al. (1985) and  R o b b a et al.
(1986), who showed that SRIH-14 has a direct inhibitory effect
on growth and functional capacity of the adrenal ZG. P a w l i k -
o w s k i et al. (1990) also reported a reduced basal proliferation
rate of these cells, probably owing to blocked basal trophic ac-
tion of angiotensin-II (A g u i l e r a et al., 1981). R e b u f f a t
et al. (1994) found that SRIH-induced atrophy of the ZG and its
parenchymal cells affected the mitochondrial and smooth endo-
plasmic reticulum cell compartments,  while K o n g et al.
(1994) showed that the rat adrenal gland manifested a high lev-
el of SRIH-receptor mRNA, implying direct somatostatine in-
fluence on the adrenal gland. However, earlier studies of M i -
l o š e v i ć et al. (1996, 1997) and  N ä s m a n et al. (1995)
showed that intracerebroventricular application of SRIH re-
duced size of the ZG and the volume of  its cells by influencing
the regulatory hypothalamic-pituitary axis.
Based on these results, it can be concluded that neonatal
application of SRIH-14 inhibits growth of the adrenal ZG and
its cells in female rats. 
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Tab. 1. Absolute  and relative volume of the adrenal cortex and ZG in female rats after neonatal treatment with SRIF-14. Values are









Control 3.5 ± 0.3 1.1 ± 0.02 92 ± 1.4 29.5 ± 1.9 
SRIH-14 2.5 ± 0.07* 
(- 30 %) 
0.7 ± 0.01* 
(- 36 %) 
85 ± 1.4* 
(- 8 %) 
23.5 ± 0.7* 
(- 20%) 
 
Tab. 2. Morphometic parameters  of adrenal zona glomerulosa in female rats after neonatal treated with SRIF-14. Values are means ±
S.D.  (n = 5), * p < 0.05.
Groups Volume of ZG cells 
(µm³) 
Volume of ZG nuclei (µm³) Total number of ZG cells (1 x 106) 
Control 1160.0 ± 0.1 109.0 ± 9.9 926.0 ± 23.6 
SRIH-14 1080.0 ± 14.1* 
(- 7 %) 
93.0 ± 0.9* 
(- 15 %) 
627.0 ± 23.6* 
(-32%) 
 
